HealthTree Logo
search more_vert
close
person Sign In / Create Account
Tests for DLBCL Patients: PET/CT Scan
Posted: Oct 18, 2023
Tests for DLBCL Patients: PET/CT Scan image

Diffuse large B-cell lymphoma (DLBCL) cells can build up in the lymph system. This causes areas like the lymph nodes, spleen, and liver to swell. To detect these enlarged areas, a positron emission tomography (PET)/computed tomography (CT) scan is used. 

Parts Of The Scan 

  • PET scan: Uses a small amount of a radioactive drug (called a tracer) to show how tissues and organs are functioning. This scan can help detect active cancer cells, as they tend to absorb more of the tracer due to the cancer cells’ higher metabolism 
  • CT scan: Uses X-rays to take slice-like pictures of the inside of the body. These pictures show the body's parts in detail and can help spot things that are not normal like enlarged lymph nodes, spleen, and liver 

Uses of the PET/CT Scan for DLBCL Patients 

  • Staging: It helps determine the stage of the disease by showing which lymph system areas are enlarged (lymph nodes, spleen, liver). This information helps determine when the DLBCL patient should start treatment.
  • Treatment response: After treatment, a PET/CT can show how well the medicine decreased cancer cells by highlighting the metabolic activity of a patient's cells.
  • Relapse detection: The scan may help find cancerous areas if the disease has come back after treatment.

How to Prepare for the Scan

Before receiving the PET/CT scan, patients may be asked to:

  • Fast: Typically, patients are advised not to eat for 4-6 hours before the test. Water is usually allowed.
  • Avoid strenuous activity: Physical activity can affect the distribution of the tracer. It's advised to avoid strenuous activity 24 hours before the scan.
  • Discuss medications: Always inform your doctor about any medications you're taking, as some might interfere with the test results.
  • Allergies and health conditions: Notify your healthcare provider of any allergies or if you are pregnant or nursing.

What to Expect During the Scan

The procedure generally involves the following steps:

  • Tracer injection: A small amount of radioactive tracer is injected into a vein.
  • Waiting period: After the injection, patients might wait for about 30-90 minutes. This allows the tracer to be absorbed by the body.
  • Scan: Patients lie down on a table that slides into the PET/CT machine. The scan usually lasts between 20-45 minutes. 

Risks and Side Effects

The amount of radiation exposure from the scan is minimal and is considered safe for most patients. However, it's essential to discuss any concerns with your healthcare provider. Mild reactions to the radioactive tracer are rare but can include headache, nausea, or rash.

Conclusion

A PET/CT scan helps DLBCL patients in a variety of ways. It provides insight into the disease's stage, shows how well treatments are working, and detecting relapse. Understanding how the scan works can help empower patients and their caregivers to make informed decisions about their care. Ask your DLBCL specialist about any concerns you have related to your PET/CT scan. 

The author Megan Heaps

about the author
Megan Heaps

Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family, sewing, and cooking.

Get the latest thought leadership on Diffuse Large B Cell Lymphoma delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for Diffuse Large B Cell Lymphoma Newsletter" for Diffuse Large B Cell Lymphoma news, life with Diffuse Large B Cell Lymphoma stories, Diffuse Large B Cell Lymphoma clinical trials, Diffuse Large B Cell Lymphoma 101 articles and events with Diffuse Large B Cell Lymphoma experts.

Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:

Regeneron
Bristol Myers Squibb

Follow Us

facebook instagram youtube